Cases
Tivity Health, Inc. (TVTY)
Securities Class Action
Overview
Overview
- Date:
- 3/25/2019
- Company Name:
- Tivity Health, Inc.
- Stock Symbol:
- TVTY
- Class Period:
- FROM 3/6/2017 TO 11/6/2017
- Status:
- Closed/Complete
NEW YORK, March 25, 2019 – Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of Tivity Health, Inc. (NYSE: TVTY).
On November 20, 2017, a complaint was filed alleging that between March 6, 2017 and November 6, 2017, defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) Tivity Health was aware that its customer United Healthcare, Inc. planned to expand its fitness benefit to seniors, (ii) the aforementioned expansion would represent direct competition to Tivity Health’s core program SilverSneaker, and (iii) as a result of the foregoing, the company’s financial statements, as well as defendants’ statements about Tivity Health’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis. Recently the federal court presiding over the litigation denied defendants’ motion to dismiss the class action complaint, paving the way for litigation to proceed against Tivity and certain executive officer defendants.
If you purchased or otherwise acquired Tivity shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.
On November 20, 2017, a complaint was filed alleging that between March 6, 2017 and November 6, 2017, defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) Tivity Health was aware that its customer United Healthcare, Inc. planned to expand its fitness benefit to seniors, (ii) the aforementioned expansion would represent direct competition to Tivity Health’s core program SilverSneaker, and (iii) as a result of the foregoing, the company’s financial statements, as well as defendants’ statements about Tivity Health’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis. Recently the federal court presiding over the litigation denied defendants’ motion to dismiss the class action complaint, paving the way for litigation to proceed against Tivity and certain executive officer defendants.
If you purchased or otherwise acquired Tivity shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.